|
ZMYND11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.42000000646902E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.092200E-01 |
| Stage1-vs-Stage3 |
2.616500E-02 |
| Stage1-vs-Stage4 |
8.429000E-04 |
| Stage2-vs-Stage3 |
8.737600E-03 |
| Stage2-vs-Stage4 |
1.263180E-03 |
| Stage3-vs-Stage4 |
2.637400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.57720000004691E-06 |
| Normal-vs-Asian |
1.67799107941846E-12 |
| Caucasian-vs-AfricanAmerican |
6.000500E-02 |
| Caucasian-vs-Asian |
5.041600E-01 |
| AfricanAmerican-vs-Asian |
2.781000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
7.091200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.15749999999959E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.849600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.139800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.899800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.152000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.483600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.303400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.4742000000082E-05 |
| Classical-VS-Follicular |
8.626400E-04 |
| Classical-VS-Other |
7.007200E-01 |
| Classical-VS-Normal |
4.32986979603811E-15 |
| Tall-VS-Follicular |
1.71870000453822E-08 |
| Tall-VS-Other |
1.372600E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.667810E-01 |
| Follicular-VS-Normal |
3.29369997942308E-09 |
| Other-VS-Normal |
8.00570000000222E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.236160E-02 |
|
|
